2,2'-anhydro-1-(β-D-arabinofuranosyl)thymine | 215713-37-4

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二嗪类
• 英文名称: 2,2'-anhydro-1-(β-D-arabinofuranosyl)thymine
• 英文别名: thymidine nucleoside；2,2'-Anhydro-5-methyl-uridine；(2R,4R,5R,6S)-5-hydroxy-4-(hydroxymethyl)-11-methyl-3,7-dioxa-1,9-diazatricyclo[6.4.0.02,6]dodec-11-en-10-one
• CAS: 215713-37-4
• 化学式: C₁₀H₁₄N₂O₅
• 分子量: 242.232
• InChiKey: SXCZZPTZANGKOA-IWLPKDRNSA-N

物化性质

• 沸点：
  592.3±50.0 °C(Predicted)
• 密度：
  1.58±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  -0.9
• 重原子数：
  17
• 可旋转键数：
  1
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.7
• 拓扑面积：
  91.3
• 氢给体数：
  3
• 氢受体数：
  6

反应信息

• 作为反应物：
  描述：

  2,2'-anhydro-1-(β-D-arabinofuranosyl)thymine 在 氢氧化钾 、 对甲苯磺酸 作用下， 以 乙醇 、 乙腈 为溶剂， 反应 7.0h， 生成 1-(3,5-O-di(tetrahydropyran-2-yl)-β-D-arabinofuranosyl)thymine
  参考文献：
  名称：

  Novel selective human mitochondrial kinase inhibitors: Design, synthesis and enzymatic activity

  摘要：

  Selective and effective TK2 inhibitors can be obtained by introduction of bulky lipophilic chains (acyl or alkyl entities) at the 2' position of araT and BVaraU, nucleoside analogues naturally endowed with a low TK2 affinity. These derivatives showed a competitive inhibitory activity against TK2 in micromolar range. BVaraU nucleoside analogues, modified on the 2'-O-acyl chain with a terminal N-Boc amino-group, conserved or increased the inhibitory activity against TK2 (71 and 7m IC50: 6.4 and 3.8 mu M, respectively). The substitution of an ester for a carboxamide moiety at the 2' position of araT afforded a consistent reduction of the inhibitory activity (25, IC50: 480 mu M). On the contrary, modifications at 2'-OH position of araC and araG, have provided inactive derivatives against TK2 and dGK, respectively. The biological activity of a representative compound, 2'-O-decanoyl-BVaraU, was also investigated in normal human fibroblasts and was found to impair mitochondrial function due to TK2 inhibition. (c) 2007 Published by Elsevier Ltd.

  DOI：

  10.1016/j.bmc.2007.01.049
• 作为产物：
  描述：

  5-甲基尿甙 在 N-苯基邻氨基苯甲酸 、 碳酸氢钠 作用下， 生成 2,2'-anhydro-1-(β-D-arabinofuranosyl)thymine
  参考文献：
  名称：

  Sharma, Deepti; Khandelwal, Anuj; Sharma, Raman K., Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry, 2009, vol. 48, # 12, p. 1712 - 1720

  摘要：

  DOI：

文献信息

• A new protecting group ‘3′,5′-O-sulfinyl’ for xylo-nucleosides. A simple and efficient synthesis of 3′-amino-3′-deoxyadenosine (a puromycin intermediate), 2,2′-anhydro-pyrimidine nucleosides and 2′,3′-anhydro-adenosine
  作者：Ken-ichi Takatsuki、Makoto Yamamoto、Sumito Ohgushi、Shigeo Kohmoto、Keiki Kishikawa、Haruhiro Yamashita

  DOI：10.1016/j.tetlet.2003.10.092

  日期：2004.1

  We developed a new protecting group, the cyclic sulfite for the protection of the 3′,5′-dihydroxy group of nucleosides. Seven cyclic sulfites, 4a–c, 5a–b, and 6a–b were prepared in high yields from the corresponding xylo-uridines 1 and 2, and xylo-adenosines 3 with thionyl chloride, respectively. Synthesis of the puromycin intermediate 8 was carried out by deprotection of the sulfite moiety through

  我们开发了一种新的保护基团，为保护3的循环亚'，5 '核苷的二羟基组。分别由相应的木尿苷1和2以及木苷腺苷3和亚硫酰氯分别高产率地制备了七个环状亚硫酸盐4a – c，5a – b和6a – b。嘌呤霉素中间体的合成8是由亚硫酸盐部分的脱保护通过2的分子内环化进行' -α -氨基甲酸酯7。
• Antisense modulation of PTPRM expression
  申请人：Isis Pharmaceuticals, Inc.

  公开号：US20040014699A1

  公开（公告）日：2004-01-22

  Antisense compounds, compositions and methods are provided for modulating the expression of PTPRM. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding PTPRM. Methods of using these compounds for modulation of PTPRM expression and for treatment of diseases associated with expression of PTPRM are provided.

  提供了用于调节PTPRM表达的反义化合物、组合物和方法。这些组合物包括针对编码PTPRM的核酸的反义寡核苷酸。提供了使用这些化合物调节PTPRM表达和治疗与PTPRM表达相关疾病的方法。
• Sharma, Deepti; Khandelwal, Anuj; Sharma, Raman K., Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry, 2009, vol. 48, # 12, p. 1712 - 1720
  作者：Sharma, Deepti、Khandelwal, Anuj、Sharma, Raman K.、Bhatia, Sumati、Reddy, L. Chandrashekar、Olsen, Carl E.、Wengel, Jesper、Parmar, Virinder S.、Prasad, Ashok K.

  DOI：——

  日期：——
• Novel selective human mitochondrial kinase inhibitors: Design, synthesis and enzymatic activity
  作者：Nunzia Ciliberti、Stefano Manfredini、Angela Angusti、Elisa Durini、Nicola Solaroli、Silvia Vertuani、Lisa Buzzoni、Maria Cruz Bonache、Efrat Ben-Shalom、Anna Karlsson、Ann Saada、Jan Balzarini

  DOI：10.1016/j.bmc.2007.01.049

  日期：2007.4

  Selective and effective TK2 inhibitors can be obtained by introduction of bulky lipophilic chains (acyl or alkyl entities) at the 2' position of araT and BVaraU, nucleoside analogues naturally endowed with a low TK2 affinity. These derivatives showed a competitive inhibitory activity against TK2 in micromolar range. BVaraU nucleoside analogues, modified on the 2'-O-acyl chain with a terminal N-Boc amino-group, conserved or increased the inhibitory activity against TK2 (71 and 7m IC50: 6.4 and 3.8 mu M, respectively). The substitution of an ester for a carboxamide moiety at the 2' position of araT afforded a consistent reduction of the inhibitory activity (25, IC50: 480 mu M). On the contrary, modifications at 2'-OH position of araC and araG, have provided inactive derivatives against TK2 and dGK, respectively. The biological activity of a representative compound, 2'-O-decanoyl-BVaraU, was also investigated in normal human fibroblasts and was found to impair mitochondrial function due to TK2 inhibition. (c) 2007 Published by Elsevier Ltd.